Web Results
Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.

en.wikipedia.org/wiki/Denosumab

Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.

www.prolia.com/about

One shot of Prolia® (denosumab) every six months is proven to help women with postmenopausal osteoporosis at high risk for fracture strengthen their bones.

chemocare.com/chemotherapy/drug-info/denosumab.aspx

Denosumab (Prolia, Xgeva) monoclonal antibody therapy side effects, how it's given, how it works, precautions and self care tips for treatment of osteoporosis, ...

medlineplus.gov/druginfo/meds/a610023.html

Nov 15, 2016 ... Denosumab Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.

www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/denosumab

Your guide to the targeted cancer drug denosumab how you have it, when you have it and other important information.

www.drugs.com/cdi/denosumab-injection-prolia.html

Oct 4, 2017 ... Easy to read patient leaflet for Denosumab Injection (Prolia). Includes indications, proper use, special instructions, precautions, and possible ...

www.rxlist.com/prolia-drug.htm

Jun 16, 2017 ... Prolia (denosumab) is a human IgG2 monoclonal antibody with affinity and specificity for human RANKL (receptor activator of nuclear factor ...

www.ncbi.nlm.nih.gov/pubmed/18301800

Drugs Today (Barc). 2008 Jan;44(1):7-21. doi: 10.1358/dot.2008.44.1.1178467. Denosumab: RANKL inhibition in the management of bone loss. Hamdy NA(1).

www.uptodate.com/contents/search?search=Denosumab&submit=Go

UpToDate, electronic clinical resource tool for physicians and patients that provides information on Adult Primary Care and Internal Medicine, Allergy and ...